The BIESF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIESF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BIESF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View BIESF Detailed Price Forecast - CNN Money||View BIESF Detailed Summary - Google Finance|
|View BIESF Detailed Summary - Yahoo! Finance||View BIESF Stock Research & Analysis - Zacks.com|
|View BIESF Trends & Analysis - Trade-Ideas||View BIESF Major Holders - Barrons|
|View BIESF Call Transcripts - NASDAQ||View BIESF Breaking News & Analysis - Seeking Alpha|
|View BIESF Annual Report - CompanySpotlight.com||View BIESF OTC Short Report - OTCShortReport.com|
|View BIESF Fundamentals - TradeKing||View BIESF SEC Filings - Bar Chart|
|View Historical Prices for BIESF - The WSJ||View Performance/Total Return for BIESF - Morningstar|
|View the Analyst Estimates for BIESF - MarketWatch||View the Earnings History for BIESF - CNBC|
|View the BIESF Earnings - StockMarketWatch||View BIESF Buy or Sell Recommendations - MacroAxis|
|View the BIESF Bullish Patterns - American Bulls||View BIESF Short Pain Metrics - ShortPainBot.com|
|View BIESF Stock Mentions - StockTwits||View BIESF Stock Mentions - PennyStockTweets|
|View BIESF Stock Mentions - Twitter||View BIESF Investment Forum News - Investor Hub|
|View BIESF Stock Mentions - Yahoo! Message Board||View BIESF Stock Mentions - Seeking Alpha|
|View Insider Transactions for BIESF - SECform4.com||View Insider Transactions for BIESF - Insider Cow|
|View BIESF Major Holdings Summary - CNBC||View Insider Disclosure for BIESF - OTC Markets|
|View Insider Transactions for BIESF - Yahoo! Finance||View Institutional Holdings for BIESF - NASDAQ|
|View BIESF Stock Insight & Charts - FinViz.com||View BIESF Investment Charts - StockCharts.com|
|View BIESF Stock Overview & Charts - BarChart||View BIESF User Generated Charts - Trading View|
ADMA: Biotest Share Retirement Good for Shareholders
Posted on Monday June 04, 2018
ADMA Biologics, Inc. (ADMA) filed its 10-K and press release for its first quarter 2018 financial results on May 14, 2018. The highlights year to date have included the release of the first commercial batch of Nabi-HB to be manufactured under its ownership, the retirement of 8.6 million shares issued to Biotest and the grant of a patent for treating respiratory infections related to RI-002. The facility has been inspection-ready by the turn of the year and we await the arrival of the FDA inspection team.
BRIEF-Shanghai RAAS Blood Products Plans Asset Acquisition, Share Trade Remains Suspended
Posted on Thursday March 22, 2018
March 22 (Reuters) - Shanghai RAAS Blood Products Co Ltd : * SAYS IT PLANS TO BUY TIANCHENG INTERNATIONAL INVESTMENT OR ITS SUBSIDIARY VALUED AT 16 BILLION YUAN ($2.53 billion) VIA SHARE ISSUE * SAYS TIANCHENG ...
Biotest sheds U.S. business to allay U.S. concerns of Chinese takeover
Posted on Friday January 19, 2018
Biotest (BIOG.DE) said on Friday that it has sold its U.S. operations, allaying national security concerns by U.S. authorities and paving the way for the German company's sale to a Chinese investor. The Committee on Foreign Investment in the United States (CFIUS) had initially blocked the sale of the German blood plasma products maker to the Chinese investor Creat Group Corp. The sale of U.S. operations, to an undisclosed buyer and for an undisclosed price, means that Biotest's sale to Creat would proceed.
ADMA: Third Quarter 2017 Financial Results and Corporate Update
Posted on Monday November 13, 2017
By John Vandermosten, CFA NASDAQ:ADMA ADMA Biologics, Inc. (NASDAQ: ADMA) experienced its first full quarter merged with the Biotest Therapy Business Unit (BTBU) and reported 3Q:17 results on November ...